Josh Stevens is the President and Chief Commercial Officer of DayTwo, the leader in personalized health solutions based on the gut microbiome. Josh is responsible for DayTwo’s go-to-market team and operations, including ecommerce with consumers, partnering with health practitioners who make DayTwo part of their clinical tool kit for diabetics, and engaging with partners in clinical and evidence-based research to further extend DayTwo’s microbiome science into new diagnostics and therapeutic opportunities. Josh has spent over a decade in healthcare and health IT, bringing innovation to the marketplace through growth and M&A of venture-backed health IT companies. Prior to DayTwo Josh was CEO of Keas the first population health platform for self-insured employers that integrated claims, CRM, and benefit design, to help CFOs lower population risk and cost. Josh is the EIR for Healthcare and Health IT at Crosslink Capital. Josh has a BA in American History from Wesleyan University, in Middletown, Connecticut.